๐ Immunisation targets the diphtheria toxin rather than the bacterium itself. The toxin gene is carried by a bacteriophage, not bacterial DNA.
๐ About
- Caused by Corynebacterium diphtheriae (and occasionally C. ulcerans).
- Fatality rate: 5โ10%.
- The bacterium releases an exotoxin that blocks protein synthesis.
- Toxin gene is encoded by a bacteriophage (virus infecting the bacterium).
- Mild cases may go undiagnosed, making outbreaks difficult to trace.
๐ฆ Microbiology
- Gram-positive, club-shaped, non-motile rods.
- Classically arranged at angles forming โChinese letterโ shapes (V, L, W).
- Grow best at 37 ยฐC in oxygen.
- Only phage-infected strains produce exotoxin.
- Exotoxin has two subunits:
- A component: Blocks protein synthesis (RNA translation inhibition via ADP-ribosylation of EF-2).
- B component: Targets oropharynx, heart, and nerves.
- Exotoxin is a 58 kDa AโB polypeptide linked by disulphide bond.
- Effects: local necrosis, systemic toxaemia, myocarditis, and demyelinating neuritis.
โก Virulence
- Corynephage ฮฒ-infected strains release exotoxin.
- A subunit: ADP-ribosyl transferase โ inhibits elongation factor-2.
- B subunit: Guides toxin to target tissues.
๐ค Transmission
- Direct person-to-person contact.
- Inhalation of aerosolised droplets from infected individuals.
๐งโโ๏ธ Clinical Presentation (Incubation: 2โ4 days)
โ ๏ธ Suspect toxin-induced myocarditis if tachycardia is out of proportion to fever - perform frequent ECGs.
- Pharyngitis: Grey โdirtyโ pseudomembrane (fibrin + dead cells) in throat.
- Bull neck: Cervical lymphadenopathy + swelling.
- Affected sites: nose, pharynx, larynx.
- Airway obstruction risk with stridor.
- Symptoms: sore throat, fever, malaise.
- Complications:
- Myocarditis โ arrhythmias, heart block, heart failure.
- Cranial nerve palsies (diplopia, dysphagia, dysarthria).
- Laryngeal nerve palsy โ hoarseness.
๐ฌ Investigations
- Swab culture below pseudomembrane + PCR.
- Culture: Hoyleโs medium (blood tellurite) โ black colonies; Tinsdaleโs medium is an alternative.
- Strain types: gravis (severe), intermedius, mitis (milder) - based on colony/haemolysis pattern.
- Biochemical tests: Catalase, urease, nitrate reduction, cystinase, pyrazinamidase.
- Toxin detection: Elek test (precipitin line with antitoxin).
- Extra: Serotyping, phage typing, cardiac monitoring (ECG, echo).
๐ Mass vaccination in the mid-20th century led to near-eradication of diphtheria in developed countries.
๐ฉบ Management
- Supportive: ABCs, isolation, cardiac monitoring, bed rest.
- Diphtheria Antitoxin: 10,000โ30,000U IM (any age; higher if severe). Neutralises unbound toxin. โ ๏ธ Risk of anaphylaxis (horse serum origin).
- Antibiotics: IV/PO Erythromycin. Close contacts: 7 days of erythromycin (dosing by age).
- Airway: Laryngoscopy/bronchoscopy for pseudomembrane removal if obstruction risk.
- Contacts: Vaccinate or give booster; routine booster every 10 years for ongoing immunity.